Camila Vieira Ligo Teixeira

Burden and Risk Factors of All-Cause Dementia in South Asia: An Analysis of Global Health Data and a Framework for Future Dementia Longitudinal Studies in Low-Resource Settings

Dushani L. Palliyaguru, Nipuni Palliyaguru, Camila Vieira Ligo Teixeira, Nicole M. Armstrong et autres

Background: Dysregulated brain aging leads to dementia in some older adults. South Asia is one of the most populous regions of the world with a rapidly growing older adult population. Yet, very few studies have focused on quantifying the status and risk …

us, lk (code pays fourni par la source)

Episodic memory and associated cortical atrophy in amnestic early-onset and late-onset Alzheimer's disease

Cierra M. Keith, Marc W. Haut, Patrick Worhunsky, Camila Vieira Ligo Teixeira et autres

BackgroundMemory consolidation problems are often prototypical in Alzheimer's disease (AD). However, it remains undetermined whether episodic memory presents similarly in early-onset Alzheimer's disease (EOAD) relative to the more commonly occurring late-onset Alzheimer's disease (LOAD).ObjectiveThis study examined episodic memory and its neuroanatomical correlates …

us (code pays fourni par la source)

Retinal thickness is associated with global cognition and executive function in mild cognitive impairment due to Alzheimer's disease

Annahita Amireskandari, Camila Vieira Ligo Teixeira, Patrick D. Worhunsky, Cierra M. Keith et autres

Alzheimer's disease (AD) is a neurodegenerative disease that leads to cognitive impairment and dementia, and retinal imaging is being explored as a biomarker. We examined the differences in retinal thickness by optical coherence tomography (OCT) between 47 participants with mild cognitive impairment …

us (code pays fourni par la source)

Neuromodulation in Alzheimer’s disease: a review with illustrative pilot data using focused ultrasound

Marc W. Haut, Camila Vieira Ligo Teixeira, Manish Ranjan, Jeffrey Carpenter et autres

us (code pays fourni par la source)

Anti‐amyloid immunotherapy and brain volume trajectories in early‐onset versus late‐onset Alzheimer's disease

Rashi I. Mehta, Methasit Jaisa-Aad, Camila Vieira Ligo Teixeira, Patrick D. Worhunsky et autres

Abstract INTRODUCTION Accelerated brain volume loss has been observed following trials of anti‐amyloid beta immunotherapy (AAT); however, there is limited understanding of this paradoxical phenomenon in early‐onset Alzheimer's disease (EOAD) versus late‐onset Alzheimer's disease (LOAD). METHODS We retrospectively analyzed brain volume changes …

us (code pays fourni par la source)

EE136 DOES VULNERABILITY DRIVE UTILIZATION: ASSESSING DIFFERENTIAL HEALTHCARE UTILIZATION AMONG DUAL-ELIGIBLE VERSUS FEE-FOR-SERVICE MEDICARE BENEFICIARIES FROM EARLY TO MID-STAGE AD/ADRD/MCI

Marc W. Haut, Victor Finomore, Holly Phelps, Camila Vieira Ligo Teixeira et autres

us (code pays fourni par la source)

EE246 DELAYING DECLINE, REDUCING DEMAND: NEAR-TERM UTILIZATION AND COSTS ASSOCIATED WITH PROGRESSION OF ALZHEIMER’S DISEASE AMONG US MEDICARE BENEFICIARIES

Victor Finomore, Marc W. Haut, Camila Vieira Ligo Teixeira, Holly Phelps et autres

us (code pays fourni par la source)

Memory Consolidation and ARIA in Individuals Receiving Anti-amyloid Monoclonal Antibodies

Marc W. Haut, Camila Vieira Ligo Teixeira, Patrick D. Worhunsky, Rashi I. Mehta et autres

Amyloid related imaging abnormalities (ARIA) are the most significant risk associated with the use of anti-amyloid monoclonal antibodies (MAB) for Alzheimer's disease (AD). Currently, the presence of the APOE ε4 allele is the best predictor for the development of ARIA. However, the …

us (code pays fourni par la source)

Exploring Low‐Intensity Focused‐ultrasound Neuromodulation in Alzheimer's Disease

Ali R. Rezai, Camila Vieira Ligo Teixeira, Manish Ranjan, Geoffrey Grant Adams et autres

BACKGROUND: Alzheimer's disease (AD) presents a major public health challenge with few effective therapeutic options. Monoclonal antibodies targeting β-amyloid show promise, but their clinical efficacy remains modest. As such, combining pharmacological and non-pharmacological interventions to slow cognitive decline has become a key …

us (code pays fourni par la source)

Combination of focused ultrasound blood‐brain barrier opening with Lecanemab therapy in mild Alzheimer's disease

Ali R. Rezai, Pierre-François D’Haese, Victor Finomore, JS Carpenter et autres

Abstract Background Alzheimer's disease (AD) is a major neurodegenerative disorder affecting millions worldwide, with limited treatment options and significant challenges in drug delivery. Monoclonal antibody (mAb) therapies targeting β‐amyloid plaques have shown promise but are constrained by potential adverse effects, including amyloid‐related …

us (code pays fourni par la source)

Resistance training protects the hippocampus and precuneus against atrophy and benefits white matter integrity in older adults with mild cognitive impairment

Isadora Cristina Ribeiro, Camila Vieira Ligo Teixeira, Thiago Junqueira Ribeiro de Rezende, Brunno Machado de Campos et autres

br, us (code pays fourni par la source)

Interaction of insula and hippocampus in memory dysfunction in Alzheimer's disease

Michelle M. Coleman, Marc W. Haut, Camila Vieira Ligo Teixeira, Cierra M. Keith et autres

The insula, classically linked with emotion and perception, has recently been associated with memory function in Alzheimer's disease (AD). However, its role in memory remains unclear. This study investigated whether the insula contributes directly to memory consolidation or is indirectly involved in …

us (code pays fourni par la source)